BCRX
+0.04 (0.54%)
7.42
| General | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
| Comparison | ||||||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||||
News
...
Profile
...
BioCryst Pharmaceuticals, Inc., a biotechnology company, develops oral small-molecule and protein therapeutics to treat rare diseases. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat hereditary angioedema. It is also developing BCX10013, an oral factor D inhibitor for complement-mediated diseases. The company has collaborations and in-license relationships with the Torii Pharmaceutical Co., Ltd.; Seqirus UK Limited; Shionogi & Co., Ltd.; Green Cross Corporation; National Institute of Allergy and Infectious Diseases; Biomedical Advanced Research and Development Authority; the U.S. Department of Health and Human Services; and The University of Alabama at Birmingham, as well as Albert Einstein College of Medicine of Yeshiva University and Industrial Research, Ltd. BioCryst Pharmaceuticals, Inc. was founded in 1986 and is headquartered in Durham, North Carolina.
Earning
...
| Date | For | Estimate | Reported | Surprise | surprise % |
|---|---|---|---|---|---|
| 2024-11-07 | 2024-09 | -0.07 | N/A | N/A | N/A |
| 2024-08-05 | 2024-06 | -0.19 | -0.06 | 0.13 | 68.42% |
| 2024-05-06 | 2024-03 | -0.23 | -0.17 | 0.06 | 26.09% |
| 2024-02-26 | 2023-12 | -0.24 | -0.28 | -0.04 | -16.67% |
| 2023-11-02 | 2023-09 | -0.25 | -0.19 | 0.06 | 24.00% |
| 2023-08-03 | 2023-06 | -0.25 | -0.24 | 0.01 | 4.00% |
Upgrade / Downgrade
...
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| 2023-09-24 | RBC Capital | Upgrade | Outperform | Outperform |
| 2023-09-17 | RBC Capital | Upgrade | Sector Perform | Outperform |
| 2023-08-03 | RBC Capital | Upgrade | Sector Perform | Sector Perform |
| 2023-08-03 | Jefferies | Upgrade | Hold | Buy |
| 2023-08-03 | HC Wainwright & Co. | Upgrade | Buy | Buy |
| 2023-08-02 | Needham | Upgrade | Buy |
Insider Holder
...
| Date | Name | Relation | Quantity | Description |
|---|---|---|---|---|
| 2024-06-11 | ABERCROMBIE GEORGE B | Director | 36.43K | Stock Award(Grant) |
| 2024-06-11 | ASELAGE STEPHEN J | Director | 72.66K | Stock Award(Grant) |
| 2024-06-11 | GALSON STEVEN K | Director | 58.37K | Stock Award(Grant) |
| 2024-06-13 | HEGGIE THERESA | Director | 52.85K | Sale |
| 2024-06-11 | HUTSON NANCY J | Director | 93.64K | Stock Award(Grant) |
| 2024-06-11 | LEVIN ALAN G | Director | 51.77K | Stock Award(Grant) |
Institution Ownership
...
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2023-06-29 | Blackrock Inc. | 15.50M | 109.09M | 8.18% |
| 2023-06-29 | Vanguard Group Inc | 15.09M | 106.23M | 7.96% |
| 2023-06-29 | Baker Brothers Advisors, LLC | 12.71M | 89.48M | 6.71% |
| 2023-06-29 | State Street Corporation | 12.26M | 86.34M | 6.47% |
| 2023-06-29 | Avoro Capital Advisors LLC | 12.06M | 84.87M | 6.36% |
| 2023-06-29 | Assenagon Asset Management S.A. | 5.33M | 37.54M | 2.81% |
Fund Ownership
...
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2023-08-30 | SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF | 8.22M | 58.41M | 4.34% |
| 2023-06-29 | Vanguard Total Stock Market Index Fund | 5.86M | 41.26M | 3.09% |
| 2023-08-30 | iShares Russell 2000 ETF | 4.29M | 30.51M | 2.26% |
| 2023-08-30 | Fidelity Select Portfolios - Biotechnology | 2.81M | 19.96M | 1.48% |
| 2023-06-29 | Vanguard Extended Market Index Fund | 2.58M | 18.14M | 1.36% |
| 2023-06-29 | Vanguard Small-Cap Index Fund | 2.44M | 17.17M | 1.29% |
Dividend
...
| Dividend | Date |
|---|---|
| 0 | 2014-06-11 |
| 0 | 2014-06-05 |
| 0 | 2014-05-20 |
| 0 | 2014-05-16 |
| 0 | 2014-04-02 |
This topic has been deleted. Only users with topic management privileges can see it.
-
$BCRX How many out their wish they would have bailed completely back when Bio99 did in the 14.00-!6.00 range and everyone gave him a hard time
-
-
$BCRX WHERE IS THA PLUS ?
-
$BCRX It’s just plain sad!
-
-
$BCRX All you Pros don’t forget the PLUS ! You bet buddy.
-
-
$BCRX Plus what you clown!
-
-
$BCRX I guess we can forget the PLUS huh Jon ?
-
-
$BCRX MartinPlante is delusional he’s a mixed up sea turtle SCAM
-
$BCRX 15 SHARES Pre mkt.
-
$BCRX Marango give it up buddy spew your loser garbage somewhere else move on!
-
$BCRX Glad I’ve got a $1.92 avg.
-
$BCRX this could be the next CCXI….then mabe NOT!
-
$BCRX News flash we are up $3.03 from 3/15/2018 wow!
-
$BCRX I mean sell some more.
-
$BCRX 9 scripts …1.25 scripts per continent Boy we are tearing um up better buy some more shares
